Literature DB >> 32405030

A novel ITPA variant causes epileptic encephalopathy with multiple-organ dysfunction.

Masamune Sakamoto1,2, Den Kouhei1, Muzhirah Haniffa3, Sebastián Silva4, Mónica Troncoso5, Paola Santander5, Valeria Schonstedt6, Ximena Stecher6,7, Nobuhiko Okamoto8, Kohei Hamanaka1, Takeshi Mizuguchi1, Satomi Mitsuhashi1, Noriko Miyake9, Naomichi Matsumoto10.   

Abstract

Inborn errors of metabolism can cause epileptic encephalopathies. Biallelic loss-of-function variants in the ITPA gene, encoding inosine triphosphate pyrophosphatase (ITPase), have been reported in epileptic encephalopathies with lack of myelination of the posterior limb of the internal capsule, brainstem tracts, and tracts to the primary visual and motor cortices (MIM:616647). ITPase plays an important role in purine metabolism. In this study, we identified two novel homozygous ITPA variants, c.264-1 G > A and c.489-1 G > A, in two unrelated consanguineous families. The probands had epilepsy, microcephaly with characteristic magnetic resonance imaging findings (T2 hyperintensity signals in the pyramidal tracts of the internal capsule, delayed myelination, and thin corpus callosum), hypotonia, and developmental delay; both died in early infancy. Our report expands the knowledge of clinical consequences of biallelic ITPA variants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32405030     DOI: 10.1038/s10038-020-0765-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  1 in total

1.  Identification of a novel homozygous variant confirms ITPA as a developmental and epileptic encephalopathy gene.

Authors:  Parneet Kaur; Kausthubham Neethukrishna; Ali Kumble; Katta M Girisha; Anju Shukla
Journal:  Am J Med Genet A       Date:  2019-02-28       Impact factor: 2.802

  1 in total
  3 in total

1.  Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency.

Authors:  Marcello Scala; Saskia B Wortmann; Namik Kaya; Menno D Stellingwerff; Angela Pistorio; Emma Glamuzina; Clara D van Karnebeek; Cristina Skrypnyk; Katarzyna Iwanicka-Pronicka; Dorota Piekutowska-Abramczuk; Elżbieta Ciara; Frederic Tort; Beth Sheidley; Annapurna Poduri; Parul Jayakar; Anuj Jayakar; Jariya Upadia; Nicolette Walano; Tobias B Haack; Holger Prokisch; Hesham Aldhalaan; Ehsan G Karimiani; Yilmaz Yildiz; Ahmet C Ceylan; Teresa Santiago-Sim; Amy Dameron; Hui Yang; Mehran B Toosi; Farah Ashrafzadeh; Javad Akhondian; Shima Imannezhad; Hanieh S Mirzadeh; Shazia Maqbool; Aisha Farid; Mohamed A Al-Muhaizea; Meznah O Alshwameen; Lama Aldowsari; Maysoon Alsagob; Ashwaq Alyousef; Rawan AlMass; Aljouhra AlHargan; Ali H Alwadei; Maha M AlRasheed; Dilek Colak; Hanan Alqudairy; Sameena Khan; Matthew A Lines; M Ángeles García Cazorla; Antonia Ribes; Eva Morava; Farah Bibi; Shahzad Haider; Matteo P Ferla; Jenny C Taylor; Hessa S Alsaif; Abdulwahab Firdous; Mais Hashem; Chingiz Shashkin; Kairgali Koneev; Rauan Kaiyrzhanov; Stephanie Efthymiou; Queen Square Genomics; Thomas Schmitt-Mechelke; Andreas Ziegler; Mahmoud Y Issa; Hasnaa M Elbendary; Pasquale Striano; Fowzan S Alkuraya; Maha S Zaki; Joseph G Gleeson; Tahsin Stefan Barakat; Jorgen Bierau; Marjo S van der Knaap; Reza Maroofian; Henry Houlden
Journal:  Hum Mutat       Date:  2022-01-12       Impact factor: 4.700

2.  ITPA Related Developmental Encephalopathy: Key Role of Neuroimaging.

Authors:  Dilek Çavuşoğlu; Melike Ataseven Kulali; Nihal Olgaç Dündar; Cigdem Ozer Gokaslan; Kurşad Aydin
Journal:  Ann Indian Acad Neurol       Date:  2022-02-18       Impact factor: 1.383

Review 3.  Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring.

Authors:  Hong-Li Guo; Yue-Tao Zhao; Wei-Jun Wang; Na Dong; Ya-Hui Hu; Yuan-Yuan Zhang; Feng Chen; Li Zhou; Tao Li
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.